![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.35 | 4.20 | 4.50 | 4.35 | 4.35 | 4.35 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.36 | 23.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/4/2023 13:22 | As we move fur. | ![]() supersonico | |
28/4/2023 11:15 | So, ramper, explain why Sean isn't buying himself, instead inducing fools and mugs to buy. Time for some more borrowings and dilutions soon, lol. | ![]() neutralpov | |
28/4/2023 10:14 | Spot on Sean. | ![]() supersonico | |
28/4/2023 09:33 | Ferk orf Sean. | ![]() neutralpov | |
28/4/2023 09:20 | rustyke1 re your post 13990. watch You will hear how Eden has two special (unique) aspects. 1. Three active ingredients have been stabilised/harnessed and 2. it separately has an encapsulation process (which is also organic) The company you refer to is proposing an encapsulation process. Anyhow, I am expecting great things from Corteva's ever deeper relationship it has with Eden. Watch and enjoy - if you are an investor or thinking of investing. | ![]() attyg | |
27/4/2023 22:28 | Nattokinase-based supplement; Spike Support. Fortunately, you can help your body to rid and protect itself from toxic spike protein. Nattokinase, an enzyme discovered in Japan, has caught the interest of the scientific world to safely combat spike protein. Dr. Peter McCullough’s research on the substance finds Nattokinase “to be the most compelling and scientifically supported approach to clear Spike protein out of the body via proteolytic degradation.” Dr. Peter McCullough and his team at The Wellness Company designed an optimized Nattokinase-based supplement, Spike Support, to aid in recovery and mitigate the effects of future infections. This formula contains: Nattokinase to aid with circulation and dissolve spike protein Dandelion root to detoxify and prevent spike protein cellular binding Black sativa to help facilitate cellular repair Selenium to reduce stress, which aids in helping the body repair itself and recover Green tea to scavenge for free radicals at the cellular level Irish sea moss to help rebuild damaged tissue and muscle With millions of Americans suffering adverse reactions to the COVID-19 vaccination, or still not fully recovered from the COVID virus itself, as spike protein is being “shed’ from person to person, everyone should take Spike Support daily to feel their best. | ![]() supersonico | |
27/4/2023 21:21 | Canary told you so ... ‘The greatest crime against humanity’ in history: Naomi Wolf’s 11 revelations from Pfizer vaccine documents KanekoaTheGreat @KanekoaTheGreat . @NaomiRWolf 'The Greatest Crime Against Humanity In History': 11 Revelations From Pfizer's Vaccine Documents #1: Pfizer knew their gene-based injections had negative efficacy as early as November 2020 #2: Shortly after the release of the COVID injections, Pfizer moved to hire 2,400 full-time employees to process the paperwork of the injured #3: Pfizer and the FDA withheld information that the shots cause heart damage in youth for four months while an aggressive propaganda campaign drove many thousands to get injected #4: Rather than staying in the injection site, Pfizer knew the shot’s dangerous lipid nanoparticles quickly distribute throughout the body to the brain, liver, and adrenals, and accumulate in the ovaries #5: Pfizer documents acknowledge more than 42,000 adverse events, including 1,200 deaths, in just the first three months, including strokes, hemorrhages, blood clots, lung clots, leg clots, neurological disorders, dementia, guillain-barré, bell’s palsy, myalgia, and more #6: Prior to it being legal, more than 1,000 children were injected, and Pfizer’s documents indicate a high rate of serious injury #7:Available records of study participants who conceived children show 80% lost their babies #8: Pfizer knew there was a danger to fertility. Lipid Nanoparticles damage the placenta during pregnancy, causing early deliveries #9: Pfizer docs show that lipid nanoparticles also enter breast milk, stunting, injuring, and sometimes killing babies #10: Pfizer docs show 3 to 1 of AEs sustained by women, 16% ‘reproductive disorders.’ ‘What kind of monsters look at 16% reproductive disorders and keep going?’ Results: ‘13% to 20% drop in live births' #11 Pfizer documents reveal that LNPs “degrade baby boys in utero” by traversing “the testes of fetal baby boys” and damaging “the Sertoli cells and the Leydig cells, which are basically the factories of masculinity” | ![]() supersonico | |
27/4/2023 15:04 | As we move furt. | ![]() supersonico | |
27/4/2023 14:27 | Hahaha, one poltroon talking to one multiavatar sock. Couldn't make it up! ;D | ![]() neutralpov | |
27/4/2023 08:37 | Spot on AttyG. | ![]() supersonico | |
27/4/2023 08:35 | Oh we all do! Neuts and some other want it to be less than nothing - some personal issues I sense. The rich only want to get richer and they do not like losing money. Astute buying from where I'm sitting. | ![]() attyg | |
27/4/2023 08:27 | Atul is already rich and does not care if EDEN goes to 0 or 100 pence. | ![]() timbo_slice | |
27/4/2023 07:39 | I feel Atul is going to be a rich person. | ![]() attyg | |
27/4/2023 00:39 | Hi Neuts,I now feel very confident to say you're an idiot in my opinion. Please feel free to message me privately if you disagree. Mango. | ![]() timbo_slice | |
26/4/2023 20:44 | Record keeping. | ![]() supersonico | |
26/4/2023 18:52 | So? Wtf? | ![]() gemstar2 | |
26/4/2023 18:11 | NUMBER OF AIM SECURITIES IN ISSUE As of 21 March 2023, the number of shares in issue was 380,858,607. SIGNIFICANT SHAREHOLDERS As of 21 March 2023 significant shareholdings in the share capital of Eden Research plc were: Name Number of shares % of the issued ordinary share capital BGF Investment Management Limited 51,733,000 13.58% Sipcam Oxon S.p.A. 37,614,830 9.88% Hargreaves Lansdown 31,737,596 8.33% Gresham House Asset Management Limited 27,845,445 7.31% Interactive Investor 25,172,555 6.61% Canaccord Genuity Group Inc 22,584,000 5.93% JM Finn Nominees Limited 19,839,762 5.21% Atul Unadkat 18,117,567 4.76% Rathbone Nominees Limited 15,621,872 4.10% HSBC Global Custody Nominee (UK) Limited 13,066,384 3.43% Name Number of shares % of the issued ordinary share capital A Abrey 1,620,346 0.43% L van der Broek 929,500 0.24% S Smith 911,039 0.24% R Cridland 130,167 0.03% SHARES NOT IN PUBLIC HANDS In the terms of AIM Rules published July 2016 and insofar as it is aware, at 21 March 2023, 31.71% of the Company's AIM securities was not in public hands. .................... Atul keeps buying. As of 30 September 2022, the number of shares in issue was 380,858,607. As of 30 September 2022, significant shareholdings in the share capital of Eden Research plc were: Number of shares % of the issued ordinary share capital BGF Investment Management Limited 53,733,000 14.11% Sipcam Oxon S.p.A. 37,614,830 9.88% Hargreaves Lansdown 29,839,285 7.83% Gresham House Asset Management Limited 27,845,445 7.31% Canaccord Genuity Group Inc 22,584,000 5.93% Interactive Investor 20,027,730 5.26% JM Finn Nominees Limited 19,277,362 5.06% Atul Unadkat 17,545,098 4.61% Rathbone Nominees Limited 15,708,999 4.12% HSBC Global Custody Nominee (UK) Limited 13,270,588 3.48% .................... NUMBER OF AIM SECURITIES IN ISSUE As of 09 March 2022, the number of shares in issue was 380,340,229. SIGNIFICANT SHAREHOLDERS As of 09 March 2022, significant shareholdings in the share capital of Eden Research plc were: Name Number of shares % of the issued ordinary share capital BGF Investment Management Limited 54,933,000 14.44% Sipcam Oxon S.p.A. 37,614,830 9.89% Gresham House Asset Management Limited 27,845,445 7.32% Hargreaves Lansdown 25,331,396 6.66% Canaccord Genuity Group Inc 22,584,000 5.94% JM Finn Nominees Limited 20,386,275 5.36% Interactive Investor 19,790,573 5.20% Atul Unadkat 17,350,145 4.38% Rathbone Nominees Limited 16,095,276 4.24% Amati AIM VCT plc 14,282,652 3.76% HSBC Global Custody Nominee (UK) Limited 13,270,588 3.49% .................... NUMBER OF AIM SECURITIES IN ISSUE As of 18 August 2021, the number of shares in issue was 380,340,229. SIGNIFICANT SHAREHOLDERS As of 18 August 2021, significant shareholdings in the share capital of Eden Research plc were: Name Number of shares % of the issued ordinary share capital BGF Investment Management Limited 54,933,000 14.44% Sipcam Oxon S.p.A. 37,614,830 9.89% Gresham House Asset Management Limited 27,845,445 7.32% Hargreaves Lansdown 25,331,396 6.66% Canaccord Genuity Group Inc 22,584,000 5.94% JM Finn Nominees Limited 20,386,275 5.36% Interactive Investor 19,790,573 5.20% Rathbone Nominees Limited 16,122,338 4.24% Amati AIM VCT plc 14,282,652 3.76% HSBC Global Custody Nominee (UK) Limited 13,270,588 3.49% ................... Home SECURITIES INFORMATION NUMBER OF AIM SECURITIES IN ISSUE As of 21 February 2021, the number of shares in issue was 380,340,229. SIGNIFICANT SHAREHOLDERS As of 21 February 2021, significant shareholdings in the share capital of Eden Research plc were: Name Number of shares % of the issued ordinary share capital BGF Investment Management Limited 58,333,000 15.34% Sipcam Oxon S.p.A. 37,614,830 9.89% Gresham House Asset Management Limited 27,845,445 7.32% Hargreaves Lansdown 25,452,709 6.69% Canaccord Genuity Group Inc 22,584,000 5.94% JM Finn Nominees Limited 20,421,575 5.37% Amati AIM VCT plc 16,937,750 4.45% Rathbone Nominees Limited 16,156,166 4.25% Interactive Investor 15,405,978 4.05% HSBC Global Custody Nominee (UK) Limited 14,015,588 3.69% NUMBER OF AIM SECURITIES IN ISSUE As of 21 August 2020, the number of shares in issue was 380,340,229. SIGNIFICANT SHAREHOLDERS As of 21 August 2020, significant shareholdings in the share capital of Eden Research plc were: BGF Investment Management Limited 58,333,000 15.34% Sipcam Oxon S.p.A. 37,614,830 9.89% Hargreaves Lansdown 30,276,493 7.96% Gresham House Asset Management Limited 27,845,445 7.32% Canaccord Genuity Group Inc 22,684,000 5.94% JM Finn Nominees Limited 21,774,435 5.72% Amati AIM VCT plc 16,937,750 4.45% Rathbone Nominees Limited 16,246,373 4.27% HSBC Global Custody Nominee (UK) Limited 14,007,734 3.68% Interactive Investor 12,992,073 3.42% | ![]() supersonico | |
26/4/2023 15:34 | Perhaps investingisatrickyga ROTFL! | ![]() neutralpov | |
26/4/2023 08:16 | Thanks Northwick. | ![]() rustyke1 | |
26/4/2023 07:54 | rustyke1I believe the product you posted about acts as the basis of the coating itself, whereas Eden's Sustaine encapsulates their active ingredients for future release for crop protection. Sustaine is of course, plastic free. So two products for seeds, but performing different roles. | ![]() northwick | |
25/4/2023 17:43 | Read: Then try: "Wikipedia does not have an article with this name" ;-) Enough said. | ![]() neutralpov | |
25/4/2023 11:33 | How does the following proposed seed application compare/compete with the seed product Corteva is testing in collaboration with Eden? Corteva Agriscience, a global agricultural company, has partnered with Danimer Scientific, a biotechnology company specializing in biodegradable and compostable plastics, to develop sustainable solutions for the agricultural industry. The collaboration is focused on developing a biodegradable seed coating made from Danimer Scientific's proprietary biopolymer, Nodax™. The biodegradable seed coating is designed to replace traditional seed coatings, which are typically made from non-biodegradable materials such as plastic. The new coating will provide protection for the seed from pests and disease and improve seedling emergence and growth, while also being sustainable and environmentally-frie | ![]() rustyke1 | |
23/4/2023 15:38 | Upon reflection, I think I let Darren aka spadeychops off too lightly. Both financially and reputationally, where his payment to me secured a promise I would never disclose his name directly. Rest assured I've learned the lesson of being too generous to ramping filth and their accessories. This is going to end very, very badly for supersonico and for investingisatrickyga Mark my words, and also recall those used to describe the singular event of July 16, 1945. | ![]() neutralpov | |
22/4/2023 14:46 | ravenna23 21 Apr '23 - 12:04 - 13987 > Watch out for perfidious Albion So you've heard about the SFO showing interested in the sc*m. Pray, how did you? I googled for it but nothing shows up. To avoid duplication of effort, I already have a complete and enhanced (IP addresses and a few(?) deletes/edits) backup of this BB. Abingdon stars, but so do the East London Sock Army. All potentially relevant to what lies (LIES) ahead. If and when the news breaks, I imagine it will have a remarkable and enervating impact on the share price ... (giggles) | ![]() neutralpov |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions